-
公开(公告)号:CA2728893A1
公开(公告)日:2009-11-12
申请号:CA2728893
申请日:2009-04-16
Applicant: PORTOLA PHARM INC
Inventor: VENKATARAMANI CHANDRASEKAR , HUANG WOLIN , MEHROTRA MUKUND , SONG YONGHONG , XU QING , BAUER SHAWN M , PANDEY ANJALI , KANE BRIAN , JIA ZHAOZHONG J , ROSE JACK W
IPC: C07D239/48 , A61K31/506 , A61P9/00 , A61P35/00 , C07D401/12 , C07D403/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12
Abstract: The present invention is directed to compounds of formula I-V and tautomers thereof or pharmaceutically acceptable salts, esters, and prodrugs thereof which are inhibitors of syk kinase. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition syk kinase activity, methods ofinhibilion the platelet aggregation, and methods to prevent or treat a number of conditions mediated at least in part by syk kinase activity, such as cardiovascular disease, inflammatory disease and autoimune disease and cell proliferative disorder. Formula (I) Y1 is selected from the group consisting of: (a) and (b); Z is O or S; D1 is selected from the group consisting of: (a) phenyl substituted with a group, R5 (b) naphthyl (c) C3-8cycloalkyl (d) heteroaryl (e) heterocyclyl
-
公开(公告)号:SG10201805392YA
公开(公告)日:2018-08-30
申请号:SG10201805392Y
申请日:2013-06-14
Applicant: PORTOLA PHARM INC
Inventor: JIA ZHAOZHONG J , KANE BRIAN , ROSE JACK , BAUER SHAWN M , SONG YONGHONG , XU QING , PANDEY ANJALI
Abstract: 1,2,4-TRIAZINE-6-CARBOXAMIDE KINASE INHIBITORS Provided are triazine compounds for inhibiting of Syk kinase, intermediates used in making such compounds, methods for their preparation, pharmaceutical compositions thereof, methods for inhibiting Syk kinase activity, and methods for treating conditions mediated at least in part by Syk kinase activity. No Figure
-
公开(公告)号:PL2321283T3
公开(公告)日:2017-01-31
申请号:PL09755219
申请日:2009-04-16
Applicant: PORTOLA PHARM INC
Inventor: BAUER SHAWN M , JIA ZHAOZHONG J , SONG YONGHONG , XU QING , MEHROTRA MUKUND , ROSE JACK W , HUANG WOLIN , VENKATARAMANI CHANDRASEKAR , PANDEY ANJALI
IPC: C07D239/48 , A61K31/506 , A61P9/00 , A61P35/00 , C07D401/12 , C07D403/12 , C07D413/12 , C07D417/12
-
公开(公告)号:AU2013277476B2
公开(公告)日:2016-12-15
申请号:AU2013277476
申请日:2013-06-14
Applicant: PORTOLA PHARM INC
Inventor: JIA ZHAOZHONG J , KANE BRIAN , ROSE JACK , BAUER SHAWN M , SONG YONGHONG , XU QING , PANDEY ANJALI
IPC: C07D403/12 , A01N43/64 , A01N43/707 , A61K31/53 , C07D253/075 , C07D401/12 , C07D401/14 , C07D403/14 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D471/04 , C07D495/04
Abstract: Provided are triazine compounds for inhibiting of Syk kinase, intermediates used in making such compounds, methods for their preparation, pharmaceutical compositions thereof, methods for inhibiting Syk kinase activity, and methods for treating conditions mediated at least in part by Syk kinase activity.
-
公开(公告)号:SG11201408232RA
公开(公告)日:2015-01-29
申请号:SG11201408232R
申请日:2013-06-14
Applicant: PORTOLA PHARM INC
Inventor: JIA ZHAOZHONG J , KANE BRIAN , ROSE JACK , BAUER SHAWN M , SONG YONGHONG , XU QING , PANDEY ANJALI
IPC: A01N43/64 , A01N43/707 , A61K31/53
Abstract: Provided are triazine compounds for inhibiting of Syk kinase, intermediates used in making such compounds, methods for their preparation, pharmaceutical compositions thereof, methods for inhibiting Syk kinase activity, and methods for treating conditions mediated at least in part by Syk kinase activity.
-
公开(公告)号:CA2877469A1
公开(公告)日:2013-12-27
申请号:CA2877469
申请日:2013-06-14
Applicant: PORTOLA PHARM INC
Inventor: SONG YONGHONG , XU QING , SRAN ARVINDER , BAUER SHAWN M , JIA ZHAOZHONG J , KANE BRIAN , PANDEY ANJALI
IPC: A61K31/16 , A61K31/435 , A61K31/44 , C07D401/02
Abstract: Provided are picolinamide compounds for inhibiting of Syk kinase, intermediates used in making such compounds, methods for their preparation, pharmaceutical compositions thereof, methods for inhibiting Syk kinase activity, and methods for treating conditions mediated at least in part by Syk kinase activity.
-
公开(公告)号:TN2010000471A1
公开(公告)日:2012-05-24
申请号:TN2010000471
申请日:2010-10-14
Applicant: PORTOLA PHARM INC
Inventor: JIA ZHAOZHONG J , VENKATARAMANI CHANDRASEKAR , HUANG WOLIN , MEHROTRA MUKUND , SONG YONGHONG , XU QING , BAUER SHAWN M , PANDEY ANJALI , KANE BRIAN , ROSE JACK W
IPC: A61K31/506 , A61P9/00 , A61P35/00 , C07D239/48 , C07D401/12 , C07D403/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12
-
公开(公告)号:TN2010000469A1
公开(公告)日:2012-05-24
申请号:TN2010000469
申请日:2010-10-14
Applicant: PORTOLA PHARM INC
Inventor: BAUER SHAWN M , JIA ZHAOZHONG J , SONG YONGHONG , XU QING , MEHROTRA MUKUND , ROSE JACK W , HUANG WOLIN , VENKATARAMANI CHANDRASEKAR , PANDEY ANJALI
IPC: A61K31/506 , A61P9/00 , A61P35/00 , C07D239/48 , C07D401/12 , C07D403/12 , C07D413/12 , C07D417/12
-
公开(公告)号:CA2816219A1
公开(公告)日:2012-05-10
申请号:CA2816219
申请日:2011-11-01
Applicant: PORTOLA PHARM INC
Inventor: JIA ZHAOZHONG J , SONG YONGHONG , XU QING , KANE BRIAN , BAUER SHAWN M , PANDEY ANJALI
IPC: C07D213/82 , A61K31/455 , A61P35/00 , C07D401/04 , C07D401/12 , C07D401/14 , C07D405/12 , C07D405/14 , C07D495/04
Abstract: The present invention is directed to compounds of formula I and pharmaceutically acceptable salts, esters, and prodrugs thereof which are inhibitors of Syk kinase. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition Syk kinase activity, methods of inhibition the platelet aggregation, and methods to prevent or treat a number of conditions mediated at least in part by Syk kinase activity, such as Non Hodgkin's Lymphoma.
-
公开(公告)号:CO6331433A2
公开(公告)日:2011-10-20
申请号:CO10143190
申请日:2010-11-16
Applicant: PORTOLA PHARM INC
Inventor: BAUER SHAWN M , JIA ZHAOZHONG J , PANDEY ANJALI , VENKATARAMANI CHANDRASEKAR , HUANG WOLIN , ROSE JACK , MEHROTRA MUKUND , XU QING , SONG YONGHONG
IPC: A61K31/506 , A61P9/00 , C07D239/48 , C07D401/12
Abstract: La presente invención se dirige a compuestos de la Fórmula l-II y tautómeros, sales o esteroisómeros farmacéuticamente aceptables de la misma que son inhibidores de syk y/o JAK quinasas. La presente invención también se dirige a intermediarios usados para realizar dichos compuestos, a la preparación de dicho compuesto, composiciones farmacéuticas que contienen dicho compuesto, métodos de inhibición de syk y/o JAK quinasa, métodos para la inhibición de agregación de plaquetas, y métodos para evitar o tratar una cantidad de enfermedades mediadas, al menos en parte, por la actividad syk y/o JAK quinasa, como por ejemplo trombosis y Linfoma no- Hodgkin.
-
-
-
-
-
-
-
-
-